Approximately half of AIDS related lymphomas are associated with infection by gamma herpesviruses. Most commonly, Epstein-Barr virus (EBV) is found in the lymphoma cells. A small proportion of AIDS-related lymphomas (approximately 5%) contain the Kaposi's sarcoma herpesvirus (KSHV), frequently in addition to EBV. KSHV-positive lymphomas usually present as primary effusion lymphomas (PEL), although solid variants exist. While rare, PELs have been very useful to study the role of KSHV in malignancies. Study of survival signals in PEL has led us to the identification of the transcription factor NF-kB as a critical signaling pathway, and of vFLIP as the gene encoded by KSHV that elicits NF-kB activation in latently infected PEL cells. vFLIP signaling to NF-kB is necessary for tumor cell survival. With respect to the more common EBV-associated lymphomas, NF-kB is also a critical cellular survival signal;the EBV-encoded proteins LMP1 and LMP2A are the critical viral survival signals in some of these tumors. Our broad hypothesis is that viral proteins provide survival signals, and that interference with these signals can be used as a pathogen-specific therapeutic approach for viral malignancies. Our goal is to better understand EBV-associated lymphomas by performing a comprehensive analysis to dissect the viral signals that are critical for tumor cell survival, in order to use a rational combinatorial approach for the treatment of AIDS lymphomas. This will be done through the following specific aims: 1) Characterize the mechanistic basis for the critical role of LMP2A in the setting of EBV-related lymphomas;2) Evaluate EBV gene and microRNA expression in EBV+ AIDS-related lymphomas;3) Determine which EBV-encoded gene products provide survival signals in EBV-associated lymphomas. This work will reveal which viral gene products are involved in EBV lymphomagenesis and will help select viral targets for selection of appropriate owth of lymphoma cells. Our data will help elucidate how best to inhibit EBV to improve the treatment of AIDS patients with lymphoma.

Public Health Relevance

Patients with AIDS have a very high risk of developing cancer, among which are the malignant lymphomas. A substantial proportion of these lymphomas are caused by the Epstein-Barr virus (EBV). We have found that some viral products are important for lymphoma development, and when they are inhibited, the tumor cells die. This proposal is to better understand how EBV supports the growth of lymphoma cells. Our data will help elucidate how best to inhibit EBV to improve the treatment of AIDS patients with lymphoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA068939-12
Application #
7637905
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1995-07-06
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
12
Fiscal Year
2009
Total Cost
$458,900
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pathology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Nayar, Utthara; Lu, Pin; Goldstein, Rebecca L et al. (2013) Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood 122:2837-47
Giulino-Roth, Lisa; Wang, Kai; MacDonald, Theresa Y et al. (2012) Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood 120:5181-4
Giulino, Lisa; Mathew, Susan; Ballon, Gianna et al. (2011) A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood 117:4852-4
Cesarman, Ethel (2011) Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett 305:163-74
Sun, Shao-Cong; Cesarman, Ethel (2011) NF-?B as a target for oncogenic viruses. Curr Top Microbiol Immunol 349:197-244
Ballon, Gianna; Chen, Kang; Perez, Rocio et al. (2011) Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest 121:1141-53
Carbone, Antonino; Cesarman, Ethel; Gloghini, Annunziata et al. (2010) Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS 24:479-90
Di Bartolo, Daniel L; Hyjek, Elizabeth; Keller, Shannon et al. (2009) Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. J Virol 83:4308-15
Guasparri, Ilaria; Bubman, Darya; Cesarman, Ethel (2008) EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111:3813-20
Czuchlewski, David R; Csernus, Balazs; Bubman, Darya et al. (2008) Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. Am J Clin Pathol 130:957-62

Showing the most recent 10 out of 13 publications